By Alex Baldwin ( July 2, 2025, 7:59 PM BST) -- Lawyers for Accord Healthcare urged the Court of Appeal at a hearing on Wednesday to nix remaining protections for blockbuster prostate cancer therapeutic Xtandi, saying the prior judge should not have considered the context outside a poster displaying the compound when determining whether the patent was obvious....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.